Navigation Links
Crystal Diagnostics Successfully Detects Deadly Ebola Virus in less than 20 Minutes
Date:7/9/2015

Crystal Diagnostics (CDx) has successfully detected live Ebola virus with its unique liquid crystal-based rapid pathogen detection system. Those tests were conducted at the University of Texas Galveston Medical Branch Biosafety Level 4 (BSL-4) facilities. Tests demonstrated detection at variable concentrations of live Ebola Zaire in serum samples in less than 20 minutes.

The CDx Xpress System combines proprietary liquid crystal technology with highly specific antibody-coated paramagnetic microspheres to selectively capture and detect Ebola virus faster than other commercial systems.

CDx sells rapid pathogen systems in the Food Safety market to quickly and accurately detect food borne pathogens in a variety of products including meat and produce. The company’s systems are in use in commercial test labs, government agencies, universities, and research facilities, as well as food processors. The Ebola detection project is the first application outside of the food safety arena for CDx.

According to Robert F Garry, PhD, Professor of Microbiology and Immunology at the Tulane University School of Medicine, and Principal Investigator of the Viral Hemorrhagic Fever Consortium (VHFC), “The CDx system promises advantages over other rapid Ebola detection systems, in terms of automated reader results, speed, and consistency.”

President and CEO of Crystal Diagnostics, Jim Bruce, stated that, “We are delighted with the initial results, and following field trials and US Food and Drug Administration device approval, we look forward to contributing to the fight against this deadly disease.”

CDx has applied for grants from the Paul Allen Foundation and the Biomedical Advanced Research and Development Authority (BARDA) division in the U.S. Department of Health and Human Services to complete equipment automation and development of the Ebola test.

About CDx: Crystal Diagnostics was founded in 2006 and is the exclusive licensee of fundamental liquid crystal technologies developed through a research partnership between Kent State University and Northeast Ohio Medical University. For more information about the company or its Xpress Pathogen Detection System, contact CEO Jim Bruce at 720-351-4885 or visit the CDx web site http://www.crystaldiagnostics.com.

Critical reagents used in the CDx test were supplied by the Viral Hemorrhagic Fever Consortium, or "VHFC" (http://www.vhfc.org). The VHFC reagents were developed with the support of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health ("NIH/NIAID"). VHFC members Autoimmune Technologies LLC and Zalgen Labs LLC manufacture the critical reagents.

Read the full story at http://www.prweb.com/releases/2015/07/prweb12838280.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. Phytomer Launches MORPHO DESIGNER Contouring Crystal Emulsion
2. Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc.
3. Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens
4. The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor
5. The Asia-Pacific Liquid Crystal on Silicon (LCoS) display market is expected to reach $380.0 million by 2018 - New Report by MicroMarket Monitor
6. Penn team studies nanocrystals by passing them through tiny pores
7. 2-D materials crystalline defects key to new properties
8. Global and Chinese Microcrystalline Cellulose Industry Report 2014
9. Shaping the future of nanocrystals
10. A crystal wedding in the nanocosmos
11. Hepatitis B Foundation to Host Annual Crystal Ball Gala
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
Breaking Biology Technology:
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, ... security technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate ... ... NXT-ID, we look forward to their guidance and benefiting from ...
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
Breaking Biology News(10 mins):